Publications by authors named "G Bougeard"

Li-Fraumeni syndrome (LFS) is a heterogeneous predisposition to an individually variable spectrum of cancers caused by pathogenic germline variants. We used a clustering method to assign TP53 missense variants to classes based on their functional activities in experimental assays assessing biological p53 functions. Correlations with LFS phenotypes were analyzed using the public germline mutation database and validated in three LFS clinical cohorts.

View Article and Find Full Text PDF

Wilms tumors are commonly associated with predisposition syndromes. Many of these syndromes are associated with specific phenotypic features and are discussed in the related article from the AACR Pediatric Cancer Working Group. Guidelines for surveillance in this population were published in 2017, but since then several studies have identified new genes with recurrent pathogenic variants associated with increased risk for Wilms tumor development.

View Article and Find Full Text PDF

Purpose: Describe clinical characteristics and outcome of Li-Fraumeni syndrome (LFS)-associated osteosarcomas.

Methods: TP53 germline pathogenic/likely pathogenic variant carriers diagnosed with osteosarcoma in France between 1980 and 2019 were identified via the French Li-Fraumeni database at Rouen University Hospital. Sixty-five osteosarcomas in 52 patients with available clinical and histological data were included.

View Article and Find Full Text PDF
Article Synopsis
  • - Wilms tumors are linked to various predisposition syndromes, many of which involve overgrowth and an increased risk for other cancers like hepatoblastoma.
  • - In 2017, surveillance guidelines for patients at risk for Wilms tumors were established, and the AACR Pediatric Cancer Working Group recently updated these guidelines based on new research and risk data.
  • - The update aims to inform healthcare professionals—including pediatric oncologists and geneticists—about revised diagnostic criteria and to standardize surveillance recommendations in North America and Australia for patients with relevant syndromes.
View Article and Find Full Text PDF
Article Synopsis
  • * Recent studies have expanded the list of these gene variants, leading to updates on surveillance and intervention strategies for at-risk children, including early hematopoietic stem cell transplantation.
  • * A 2023 expert panel provided new recommendations for monitoring these children, emphasizing personalized approaches based on genetic profiles, including regular check-ups and specialized testing like bone marrow examinations and gene sequencing.
View Article and Find Full Text PDF